Description
RIFAMPICIN 100 mg + ISONIAZID 50 mg + PYRAZINAMIDE 250 mg TABLET
Rifampicin Isoniazid pyrazinamide Tablets
WHO-GMP | High-Potency FDC | Global TB Programs
Healthy Incorporation & Healthy Life Pharma Pvt. Ltd. operate as a unified, end-to-end, WHO-GMP certified pharma manufacturing ecosystem delivering scalable TB formulations for global public health programs, tenders, and B2B procurement networks. With 45+ years of formulation expertise, deep regulatory discipline, and export footprints across Africa, LATAM, Asia, Middle East, and CIS, we manufacture and supply robust Anti-TB FDCs at volume, speed, and compliance.
Product Overview
This fixed-dose combination tablet contains Rifampicin 100 mg, Isoniazid 50 mg, and Pyrazinamide 250 mg, engineered for standardized first-line TB therapy protocols. Designed for precision potency, strong bioavailability, and consistent dissolution, this FDC simplifies patient adherence and aligns with WHO-recommended intensive-phase TB regimens.
Why Global Buyers Prefer Our TB FDCs
WHO-GMP + ISO-certified manufacturing
Regulatory-ready dossiers (CTD/ACTD)
High batch consistency for government tenders
Dedicated TB formulation line for contamination-controlled production
Robust QC/QA, stability data, and validated processes
Export-ready packaging (English/French/Portuguese/Arabic options)
Therapeutic Use
First-line treatment of Pulmonary & Extrapulmonary Tuberculosis
Standard regimen for intensive phase TB therapy
Designed for National TB Control Programs (NTCP) and global NGO procurement
How the Combination Works
Rifampicin: Inhibits bacterial RNA synthesis; core sterilizing agent.
Isoniazid (INH): Blocks mycolic acid synthesis; essential for early bacterial kill.
Pyrazinamide (PZA): Targets dormant TB bacilli in acidic environments, boosting sterilizing action.
This triple-action synergy ensures strong early bacterial load reduction and reduces the risk of drug-resistant TB.
Product Specifications
Product Name: Rifampicin + Isoniazid + Pyrazinamide Tablets
Strengths: 100 mg + 50 mg + 250 mg
Therapeutic Class: Anti-Tuberculosis
Form: Film-coated tablet
Packing: 10 Tablets / Box (customized export packaging available)
Dosage: As prescribed by physician under a supervised TB program
Category: Fixed Dose Combination (FDC)
Precautions
Patients must inform their clinician if they have:
Diabetes
Liver or kidney disease
Bleeding disorders
Genetic enzyme deficiencies
Pregnancy or breastfeeding plans
Avoid alcohol during therapy due to potential hepatotoxicity.
Possible Side Effects
Generally mild and temporary:
Nausea, vomiting, diarrhea, heartburn, stomach upset, fever, headache, dizziness, muscle weakness, drowsiness, numbness, or confusion.
Manufacturing Excellence
Healthy Incorporation & Healthy Life Pharma Pvt. Ltd. operate multi-line facilities producing:
Tablets, capsules, injections, dry syrups
Liquid orals, ointments, pre-filled syringes
Contract manufacturing & private-label options
Full documentation support for tender filings
Global Supply & Export Markets
We supply governments, NGOs, UN/WHO-linked health programs, procurement agencies, pharmaceutical importers, hospital chains, and TB control missions across:
Africa | LATAM | Middle East | Asia | CIS | Island Nations
Contact for Procurement & Bulk Orders
+91 7710003340
For dossiers, COAs, quotations, or export documentation, connect with our regulatory & sales team.
Custom formulations & additional strengths available on request.
Disclaimer: All intellectual property, product data, and content belong to Healthy Incorporation & Healthy Life Pharma Pvt. Ltd. Unauthorized usage is prohibited. Connect with our team for validated specifications, regulatory requirements, and tailored procurement support.
